134 related articles for article (PubMed ID: 34752544)
21. Stability of propranolol hydrochloride suspension compounded from tablets.
Henry DW; Repta AJ; Smith FM; White SJ
Am J Hosp Pharm; 1986 Jun; 43(6):1492-5. PubMed ID: 3728486
[TBL] [Abstract][Full Text] [Related]
22. Long-term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration.
Adin D; Johnson PR; Kim CH; Nguyenba T; Rosen S
J Vet Intern Med; 2017 Nov; 31(6):1822-1826. PubMed ID: 28913839
[TBL] [Abstract][Full Text] [Related]
23. Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE; Cober MP; Thome T; Rouse E
Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
[TBL] [Abstract][Full Text] [Related]
24. Formulation and stability of diazepam suspension compounded from tablets.
Strom JG; Kalu AU
Am J Hosp Pharm; 1986 Jun; 43(6):1489-91. PubMed ID: 3728485
[TBL] [Abstract][Full Text] [Related]
25. Stability of sotalol hydrochloride in extemporaneously prepared oral suspension formulations.
Sidhom MB; Rivera N; Almoazen H; Taft DR; Kirschenbaum HL
Int J Pharm Compd; 2005; 9(5):402-6. PubMed ID: 23925139
[TBL] [Abstract][Full Text] [Related]
26. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
[TBL] [Abstract][Full Text] [Related]
27. Stability of levetiracetam in extemporaneously compounded suspensions.
Ensom MH; Decarie D; Rudolph S
Can J Hosp Pharm; 2011 May; 64(3):207-11. PubMed ID: 22479056
[TBL] [Abstract][Full Text] [Related]
28. In Vitro Assessment of Compounded Lurasidone Suspensions for Enteral Feeding Tubes.
Wojcinski J; Nathan K; Zhao F
Hosp Pharm; 2023 Jun; 58(3):304-308. PubMed ID: 37216072
[No Abstract] [Full Text] [Related]
29. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z
Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863
[TBL] [Abstract][Full Text] [Related]
30. Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
Pramar YV; Mandal TK; Bostanian LA; Nguyen AT; Miller V; Morris TC; Graves RA
Int J Pharm Compd; 2019; 23(1):70-76. PubMed ID: 30668538
[TBL] [Abstract][Full Text] [Related]
31. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
Caruthers RL; Johnson CE
Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
[TBL] [Abstract][Full Text] [Related]
32. Stability of an extemporaneously prepared clopidogrel oral suspension.
Skillman KL; Caruthers RL; Johnson CE
Am J Health Syst Pharm; 2010 Apr; 67(7):559-61. PubMed ID: 20237383
[TBL] [Abstract][Full Text] [Related]
33. Compounded Apixaban Suspensions for Enteral Feeding Tubes.
Caraballo ML; Donmez S; Nathan K; Zhao F
Hosp Pharm; 2017 Jul; 52(7):478-482. PubMed ID: 29326482
[No Abstract] [Full Text] [Related]
34. Stability of an extemporaneously compounded minoxidil oral suspension.
Song Y; Chin ZW; Ellis D; Lwin EMP; Turner S; Williams D; Garg S
Am J Health Syst Pharm; 2018 Mar; 75(5):309-315. PubMed ID: 29472513
[TBL] [Abstract][Full Text] [Related]
35. Stability of propranolol in extemporaneously compounded suspensions.
Ensom MH; Kendrick J; Rudolph S; Decarie D
Can J Hosp Pharm; 2013 Mar; 66(2):118-24. PubMed ID: 23616676
[TBL] [Abstract][Full Text] [Related]
36. Comparative Stability of Compounded Omeprazole Suspension Versus Commercial Omeprazole Kit When Stored in Oral Syringes Under Refrigerated Conditions.
Jackson R; Lewis P; Brown SD
J Pharm Technol; 2020 Oct; 36(5):179-186. PubMed ID: 34752549
[No Abstract] [Full Text] [Related]
37. Stability of Adderall in extemporaneously compounded oral liquids.
Justice J; Kupiec TC; Matthews P; Cardona P
Am J Health Syst Pharm; 2001 Aug; 58(15):1418-21. PubMed ID: 11494787
[TBL] [Abstract][Full Text] [Related]
38. Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE; Cober MP; Hawkins KA; Julian JD
Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
[TBL] [Abstract][Full Text] [Related]
39. Stability of allopurinol and of five antineoplastics in suspension.
Dressman JB; Poust RI
Am J Hosp Pharm; 1983 Apr; 40(4):616-8. PubMed ID: 6846371
[TBL] [Abstract][Full Text] [Related]
40. Chemical stability of extemporaneously prepared Lorazepam suspension at two temperatures.
Lee WM; Lugo RA; Rusho WJ; Mackay M; Sweeley J
J Pediatr Pharmacol Ther; 2004 Oct; 9(4):254-8. PubMed ID: 23118704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
